Hajar Yaghoobi

901 total citations
35 papers, 669 citations indexed

About

Hajar Yaghoobi is a scholar working on Molecular Biology, Cancer Research and Parasitology. According to data from OpenAlex, Hajar Yaghoobi has authored 35 papers receiving a total of 669 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Cancer Research and 4 papers in Parasitology. Recurrent topics in Hajar Yaghoobi's work include MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (5 papers) and Circular RNAs in diseases (4 papers). Hajar Yaghoobi is often cited by papers focused on MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (5 papers) and Circular RNAs in diseases (4 papers). Hajar Yaghoobi collaborates with scholars based in Iran, South Africa and Canada. Hajar Yaghoobi's co-authors include Mehrdad Khatami, Abbas Alibakhshi, Rajender S. Varma, Vinod Kumar, Mina Sarani, Niloofar Zafarnia, Ahad Mokhtarzadeh, Hakim Azizi, Fatemeh Abarghooi Kahaki and Fatemeh Yarian and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Controlled Release.

In The Last Decade

Hajar Yaghoobi

33 papers receiving 661 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hajar Yaghoobi Iran 12 264 194 149 139 82 35 669
Jingga Morry United States 10 329 1.2× 113 0.6× 164 1.1× 157 1.1× 68 0.8× 13 779
Mahwash Mukhtar Hungary 19 247 0.9× 175 0.9× 232 1.6× 230 1.7× 35 0.4× 26 819
Renzon Daniel Cosme Pecho Peru 10 277 1.0× 150 0.8× 240 1.6× 215 1.5× 82 1.0× 22 788
Zhenghao Zhang China 14 288 1.1× 121 0.6× 129 0.9× 155 1.1× 37 0.5× 53 936
Sevda Jafari Iran 15 205 0.8× 219 1.1× 237 1.6× 179 1.3× 50 0.6× 30 874
Mohammad Mahdi Nejadi Babadaei Iran 17 224 0.8× 124 0.6× 202 1.4× 102 0.7× 30 0.4× 22 637
Rosita Primavera United States 16 239 0.9× 181 0.9× 306 2.1× 259 1.9× 26 0.3× 30 935
Phuong Ha-Lien Tran Vietnam 17 248 0.9× 143 0.7× 162 1.1× 263 1.9× 33 0.4× 20 788
Chin Siang Kue Malaysia 13 191 0.7× 255 1.3× 356 2.4× 148 1.1× 26 0.3× 35 748
Shuting Lu China 21 233 0.9× 402 2.1× 455 3.1× 233 1.7× 60 0.7× 55 1.1k

Countries citing papers authored by Hajar Yaghoobi

Since Specialization
Citations

This map shows the geographic impact of Hajar Yaghoobi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hajar Yaghoobi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hajar Yaghoobi more than expected).

Fields of papers citing papers by Hajar Yaghoobi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hajar Yaghoobi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hajar Yaghoobi. The network helps show where Hajar Yaghoobi may publish in the future.

Co-authorship network of co-authors of Hajar Yaghoobi

This figure shows the co-authorship network connecting the top 25 collaborators of Hajar Yaghoobi. A scholar is included among the top collaborators of Hajar Yaghoobi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hajar Yaghoobi. Hajar Yaghoobi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abdi, N., et al.. (2025). Investigating the role of exosomal long non-coding RNAs in drug resistance within female reproductive system cancers. Frontiers in Cell and Developmental Biology. 13. 1485422–1485422. 5 indexed citations
2.
3.
Khatami, Mehrdad, et al.. (2024). Cerium Oxide Nanoparticles Synthesis using Alhagi Maurorum Leaf Extract andEvaluation of Their Cytotoxic Effect on Breast Cancer Cell Lines and AntibacterialEffects. Anti-Cancer Agents in Medicinal Chemistry. 24(14). 1056–1062. 1 indexed citations
4.
Mirzaei, Seyed Abbas, et al.. (2024). Valproate modulates the activity of multidrug resistance efflux pumps, as a chemoresistance factor in gastric cancer cells. Molecular Biology Reports. 51(1). 427–427. 3 indexed citations
5.
Yaghoobi, Hajar, et al.. (2023). A comprehensive review of cancer therapies mediated by conjugated gold nanoparticles with nucleic acid. International Journal of Biological Macromolecules. 253(Pt 5). 127184–127184. 12 indexed citations
6.
Yaghoobi, Hajar, et al.. (2023). Effect of Alhagi maurorum Hydroalcoholic Extract on Preventing Secondary Hydatid Cysts in BALB/c Mice. Jundishapur Journal of Natural Pharmaceutical Products. 18(3). 1 indexed citations
7.
Ghasemi, Zahra, et al.. (2023). MiR‐548 K regulatory effect on the ABCG2 gene expression in MDR breast cancer cells. Cancer Reports. 6(6). e1816–e1816. 6 indexed citations
8.
9.
Yaghoobi, Hajar, et al.. (2022). Designed miR-19a/b sponge induces apoptosis in lung cancer cells through the PI3K-PTEN-Akt pathway regulation. Molecular Biology Reports. 49(9). 8485–8493. 7 indexed citations
10.
Ghatrehsamani, Mahdi, et al.. (2022). CRISPR/Cas9 as precision and high-throughput genetic engineering tools in gastrointestinal cancer research and therapy. International Journal of Biological Macromolecules. 223(Pt A). 732–754. 19 indexed citations
11.
Rostami, Soodabeh, Shima Gharibi, Hajar Yaghoobi, et al.. (2022). Herbal Medicines as Potential Inhibitors of SARS-CoV-2 Infection. Current Pharmaceutical Design. 28(29). 2375–2386. 2 indexed citations
12.
Yaghoobi, Hajar, Hakim Azizi, Mehdi Banitalebi-Dehkordi, et al.. (2019). Beta-Secretase 1 (BACE1) Is Down-Regulated in Invasive Ductal Carcinoma of Breast.. PubMed. 8(2). 200–207. 12 indexed citations
13.
Azizi, Hakim, Ali Bazı, Ali Khamesipour, et al.. (2019). A Survey on the Adjuvant Role of Naloxone Alone or Combined with Alum in Vaccination Against Fasciolosis in BALB/c Mice. Acta Parasitologica. 64(2). 236–245. 1 indexed citations
14.
Mirfakhraie, Reza, Mir Davood Omrani, Hamid Ghaedi, et al.. (2018). Idiopathic Premature Ovarian Failure and its association to the abnormal longitudinal changes of telomere length in a population of Iranian Infertile Women: A pilot study. Meta Gene. 18. 58–61. 5 indexed citations
15.
Azizi, Hakim, Ali Akbar Nasiri, Ali Bazı, et al.. (2018). Naltrexone; as an efficient adjuvant in induction of Th1 immunity and protection against Fasciola hepatica infection. Experimental Parasitology. 189. 66–71. 9 indexed citations
16.
Yaghoobi, Hajar, Bahram Kazemi, & Mojgan Bandehpour. (2017). Sensitization of Radio-Resistant Lung Cancer Cells with a B Subunit of Bacterial Cytolethal Distending Toxin from Aggregatibacter actinomycetemcomitans. Iranian Journal of Cancer Prevention. In Press(In Press). 3 indexed citations
17.
Yaghoobi, Hajar, et al.. (2016). Evaluation of the Coagulant Effect of Zanjani and Latifi Viper Snake Venom Endemic in Iran. SHILAP Revista de lepidopterología. 2 indexed citations
18.
Azizi, Hakim, Bahram Kazemi, Mojgan Bandehpour, et al.. (2016). Modulation of the Immune Response to DNA Vaccine Encoding Gene of 8-kDa Subunit of Echinococcus granulosus Antigen B Using Murine Interleukin-12 Plasmid in BALB/c Mice.. SHILAP Revista de lepidopterología. 11(4). 480–489. 4 indexed citations
19.
Yaghoobi, Hajar, Mojgan Bandehpour, & Bahram Kazemi. (2016). Apoptotic Effects of the B Subunit of Bacterial Cytolethal Distending Toxin on the A549 Lung Cancer Cell Line. Asian Pacific Journal of Cancer Prevention. 17(sup3). 299–304. 15 indexed citations
20.
Hosseini, Seyed Hamzeh, et al.. (2015). Analysing Axis One Psychiatric Disorders in Fibromyalgia Patients. Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Māzandarān/Journal of Mazandaran University of Medical Sciences. 24(122). 348–353. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jingga Morry Breakdown of academic impact, for papers by Mahwash Mukhtar Breakdown of academic impact, for papers by Renzon Daniel Cosme Pecho Breakdown of academic impact, for papers by Zhenghao Zhang Breakdown of academic impact, for papers by Sevda Jafari Breakdown of academic impact, for papers by Mohammad Mahdi Nejadi Babadaei Breakdown of academic impact, for papers by Rosita Primavera Breakdown of academic impact, for papers by Phuong Ha-Lien Tran Breakdown of academic impact, for papers by Chin Siang Kue Breakdown of academic impact, for papers by Shuting Lu
Rankless by CCL
2026